|
BBIO
|
BridgeBio Pharma, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
RNA
|
Avidity Biosciences, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
CDMO
|
Avid Bioservices, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
0.39%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.38%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.35%
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
0.35%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.33%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.32%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.32%
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
0.30%
|
US
|
NYSE
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.29%
|
US
|
NASDAQ
|